Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Journal of Acquired Immune Deficiency Syndromes (1999)|June 11, 2009
Bacterial meningitis in HIV-1-infected patients in the era of highly active antiretroviral therapyPere Domingo, Ignacio Suarez-Lozano, Ferran Torres, et al.Journal of Neurology|April 30, 2022
Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptomsMarco Calabria, Carmen García-Sánchez, Nicholas Grunden, et al.The Journal of Infection|December 6, 2011
Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamasesJesús Rodríguez-Baño, Elisenda Miró, Macarena Villar, et al.Clinical Immunology (Orlando, Fla.)|November 15, 2020
Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohortHèctor Corominas, Ivan Castellví, Virginia Pomar, et al.Journal of Global Antimicrobial Resistance|June 3, 2019
Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clonesMaría M Montero, Sandra Domene Ochoa, Carla López-Causapé, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2014
Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infectionsCarmen Peña, Gabriel Cabot, Silvia Gómez-Zorrilla, et al.Antimicrobial Agents and Chemotherapy|February 12, 2020
Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an <i>In Vitro</i> Pharmacodynamic ModelMaría Montero, Sandra Domene Ochoa, Carla López-Causapé, et al.Plos One|November 19, 2010
Uridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndromePere Domingo, Javier Torres-Torronteras, Virginia Pomar, et al.Emerging Infectious Diseases|October 3, 2022
Effects of the COVID-19 Pandemic on Incidence and Epidemiology of Catheter-Related Bacteremia, SpainOriol Gasch, Laia Badia-Cebada, Joao Carmezim, et al.Antibiotics (Basel, Switzerland)|May 27, 2023
Randomized Clinical Trial of the Need for Antibiotic Treatment for Low-Risk Catheter-Related Bloodstream Infection Caused by Coagulase-Negative StaphylococciLaia Badia-Cebada, João Carmezim, María-Teresa Pérez-Rodríguez, et al.Pageof 5